Deerfield Management as of June 30, 2017
Portfolio Holdings for Deerfield Management
Deerfield Management holds 83 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 10.1 | $190M | 2.3M | 82.16 | |
| Gilead Sciences (GILD) | 6.4 | $120M | 1.7M | 70.78 | |
| Horizon Pharma | 5.7 | $107M | 9.0M | 11.87 | |
| NxStage Medical | 5.1 | $96M | 3.8M | 25.07 | |
| Horizon Pharma Plc convertible security | 3.4 | $64M | 74M | 0.86 | |
| Mylan Nv | 2.8 | $53M | 1.4M | 38.82 | |
| Mallinckrodt Pub | 2.8 | $53M | 1.2M | 44.81 | |
| McKesson Corporation (MCK) | 2.8 | $52M | 315k | 164.54 | |
| Aerie Pharmaceuticals | 2.7 | $51M | 961k | 52.55 | |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.4 | $45M | 42M | 1.06 | |
| Kempharm Inc note 5.500% 2/0 | 2.4 | $44M | 75M | 0.59 | |
| Flamel Technologies Sa | 2.1 | $40M | 3.7M | 11.03 | |
| Trn 4% 04/01/45 | 2.0 | $38M | 48M | 0.80 | |
| Glaukos (GKOS) | 2.0 | $37M | 895k | 41.47 | |
| Gw Pharmaceuticals Plc ads | 1.9 | $36M | 360k | 100.25 | |
| Endologix, Inc. 3.25% 11/01/2020 | 1.8 | $34M | 41M | 0.85 | |
| Intersect Ent | 1.8 | $33M | 1.2M | 27.95 | |
| Audentes Therapeutics | 1.8 | $33M | 1.7M | 19.13 | |
| Lannett Company | 1.7 | $31M | 1.5M | 20.40 | |
| Nevro Corp note 1.750% 6/0 | 1.6 | $30M | 28M | 1.07 | |
| Editas Medicine (EDIT) | 1.5 | $29M | 1.7M | 16.78 | |
| Nevro (NVRO) | 1.5 | $28M | 376k | 74.43 | |
| Dbv Technologies S A | 1.3 | $24M | 665k | 35.71 | |
| Portola Pharmaceuticals | 1.3 | $24M | 419k | 56.17 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $22M | 4.0M | 5.56 | |
| Intercept Pharmas conv | 1.2 | $22M | 23M | 0.98 | |
| Selecta Biosciences | 1.1 | $21M | 1.1M | 19.86 | |
| Syros Pharmaceuticals | 1.1 | $20M | 1.3M | 16.09 | |
| Loxo Oncology | 1.1 | $20M | 251k | 80.19 | |
| Aetna | 1.1 | $20M | 130k | 151.83 | |
| Patterson Companies (PDCO) | 1.0 | $19M | 393k | 46.95 | |
| Dex (DXCM) | 1.0 | $18M | 248k | 73.15 | |
| Fluidigm Corporation convertible cor | 0.9 | $17M | 28M | 0.62 | |
| Oxford Immunotec Global | 0.8 | $16M | 946k | 16.82 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.8 | $15M | 393k | 39.04 | |
| Galapagos Nv- (GLPG) | 0.8 | $14M | 188k | 76.52 | |
| Anthem (ELV) | 0.8 | $14M | 75k | 188.13 | |
| Wave Life Sciences (WVE) | 0.7 | $14M | 747k | 18.60 | |
| Aac Holdings | 0.7 | $14M | 2.0M | 6.93 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.7 | $13M | 17M | 0.81 | |
| Recro Pharma | 0.7 | $13M | 1.9M | 7.03 | |
| Anaptysbio Inc Common (ANAB) | 0.7 | $13M | 553k | 23.93 | |
| eHealth (EHTH) | 0.7 | $13M | 690k | 18.80 | |
| Xencor (XNCR) | 0.6 | $12M | 562k | 21.11 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $12M | 757k | 15.50 | |
| Ardelyx (ARDX) | 0.6 | $12M | 2.3M | 5.10 | |
| Ascendis Pharma A S (ASND) | 0.6 | $12M | 420k | 27.76 | |
| Axogen (AXGN) | 0.6 | $11M | 674k | 16.75 | |
| Argenx Se (ARGX) | 0.6 | $11M | 509k | 21.21 | |
| Neos Therapeutics | 0.6 | $11M | 1.5M | 7.30 | |
| Molina Healthcare (MOH) | 0.6 | $11M | 152k | 69.18 | |
| Blueprint Medicines (BPMC) | 0.6 | $10M | 203k | 50.67 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $10M | 375k | 27.12 | |
| Epizyme | 0.5 | $10M | 662k | 15.10 | |
| Allscripts Healthcare So conv | 0.5 | $9.9M | 9.7M | 1.02 | |
| Sangamo Biosciences (SGMO) | 0.5 | $9.6M | 1.1M | 8.80 | |
| Centene Corporation (CNC) | 0.5 | $9.5M | 119k | 79.88 | |
| Puma Biotechnology (PBYI) | 0.5 | $9.1M | 104k | 87.40 | |
| Steadymed | 0.5 | $9.1M | 1.4M | 6.30 | |
| Nivalis Therapeutics | 0.5 | $9.0M | 3.7M | 2.41 | |
| Invuity | 0.5 | $8.5M | 1.2M | 7.25 | |
| Select Medical Holdings Corporation (SEM) | 0.4 | $7.7M | 505k | 15.35 | |
| Arena Pharmaceuticals | 0.4 | $7.0M | 417k | 16.87 | |
| Alimera Sciences | 0.3 | $6.6M | 4.8M | 1.39 | |
| Axovant Sciences | 0.3 | $5.5M | 239k | 23.19 | |
| Biohaven Pharmaceutical Holding | 0.3 | $5.4M | 217k | 25.00 | |
| Myovant Sciences | 0.2 | $4.7M | 401k | 11.70 | |
| Sierra Oncology | 0.2 | $4.1M | 3.5M | 1.17 | |
| Foamix Pharmaceuticals | 0.2 | $3.8M | 817k | 4.64 | |
| Akari Therapeutics | 0.2 | $3.8M | 818k | 4.61 | |
| Myokardia | 0.2 | $3.7M | 280k | 13.10 | |
| Mannkind (MNKD) | 0.2 | $3.8M | 2.7M | 1.41 | |
| BioScrip | 0.2 | $3.6M | 1.3M | 2.71 | |
| Agile Therapeutics | 0.2 | $3.6M | 955k | 3.75 | |
| Jounce Therapeutics | 0.2 | $3.5M | 248k | 14.03 | |
| Kempharm | 0.1 | $2.8M | 705k | 4.00 | |
| Aralez Pharmaceuticals | 0.1 | $2.2M | 1.6M | 1.35 | |
| Proteon Therapeutics | 0.1 | $1.9M | 1.2M | 1.53 | |
| Obalon Therapeutics | 0.1 | $1.8M | 183k | 9.91 | |
| Ra Pharmaceuticals | 0.1 | $1.5M | 83k | 18.74 | |
| Voyager Therapeutics (VYGR) | 0.1 | $1.1M | 118k | 8.96 | |
| Essa Pharma | 0.0 | $779k | 1.4M | 0.55 | |
| Proteostasis Therapeutics In | 0.0 | $81k | 17k | 4.70 |
